Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22989201

Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression

Author
THASE, Michael E1 ; NIERENBERG, Andrew A2 ; VRIJLAND, Peter3 ; VAN OERS, Helga J. J3 ; SCHUTTE, Albert-Jan4 ; SIMMONS, John H4
[1] University of Pennsylvania School of Medicine, Suite, Philadelphia, United States
[2] Massachusetts General Hospital, Boston, MA, United States
[3] Organon International Inc., Molenstraat, Netherlands
[4] Organon International Inc., Roseland, New Jersey, United States
Source

International clinical psychopharmacology. 2010, Vol 25, Num 4, pp 189-198, 10 p ; ref : 3/4 p

ISSN
0268-1315
Scientific domain
Cognition; Pharmacology drugs; Psychology, psychopathology, psychiatry
Publisher
Lippincott Williams & Wilkins, Hagerstown, MD
Publication country
United States
Document type
Article
Language
English
Author keyword
controlled-trial meta-analysis mirtazapine remission selective serotonin reuptake inhibitors
Keyword (fr)
Aigu Antidépresseur Article synthèse Etat dépressif Homme Inhibiteur sélectif recapture sérotonine Mirtazapine Métaanalyse Psychotrope Rémission Traitement Antagoniste Composé tétracyclique Récepteur α2-adrénergique Trouble de l'humeur
Keyword (en)
Acute Antidepressant agent Review Depression Human Selective serotonin reuptake inhibitor Mirtazapine Metaanalysis Psychotropic Remission Treatment Antagonist Tetracyclic compound α2-Adrenergic receptor Mood disorder
Keyword (es)
Agudo Antidepresor Artículo síntesis Estado depresivo Hombre Inhibidor selectivo recaptura serotonin Mirtazapina Meta-análisis Psicotropo Remisión Tratamiento Antagonista Compuesto tetracíclico Receptor α2-adrenérgico Trastorno humor
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C07 Mood disorders / 002B18C07A Depression

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03G Mood disorders / 770-D03G01 Depression

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer…

Discipline
Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
Origin
Inist-CNRS
Database
FRANCIS ; PASCAL
INIST identifier
22989201

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web